Schrödinger has hired researchers from Eisai and Merck to support the progress of its wholly owned assets toward the clinic. News of the hires comes weeks after Schrödinger pulled in more cash to fund its evolution into a biotech with an internal pipeline.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,